Literature DB >> 3021993

Nucleotide sequence of human endogenous retrovirus genome related to the mouse mammary tumor virus genome.

M Ono, T Yasunaga, T Miyata, H Ushikubo.   

Abstract

We determined the complete nucleotide sequence of the human endogenous retrovirus genome HERV-K10 isolated as the sequence homologous to the Syrian hamster intracisternal A-particle (type A retrovirus) genome. HERV-K10 is 9,179 base pairs long with long terminal repeats of 968 base pairs at both ends; a sequence 290 base pairs long, however, was found to be deleted. It was concluded that a composite genome having the 290-base-pair fragment is the prototype HERV-K provirus gag (666 codons), protease (334 codons), pol (937 codons), and env (618 codons) genes. The size of the protease gene product of HERV-K is essentially the same as that of A- and D-type oncoviruses but nearly twice that of other retroviruses. A comparison of the deduced amino acid sequences encoded by the pol region showed HERV-K to be closely related to types A and D retroviruses and even more so to type B retrovirus. It was noted that the env gene product of HERV-K structurally resembles the mouse mammary tumor virus (type B retrovirus) env protein, and the possible expression of the HERV-K env gene in human breast cancer cells is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021993      PMCID: PMC288930     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Molecular cloning and long terminal repeat sequences of human endogenous retrovirus genes related to types A and B retrovirus genes.

Authors:  M Ono
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

2.  A human protein related to the major envelope protein of murine mammary tumor virus: identification and characterization.

Authors:  A S Dion; D C Farwell; A A Pomenti; A J Girardi
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA.

Authors:  R M Lawn; E F Fritsch; R C Parker; G Blake; T Maniatis
Journal:  Cell       Date:  1978-12       Impact factor: 41.582

6.  Sequences homologous to retrovirus-like genes of the mouse are present in multiple copies in the Syrian hamster genome.

Authors:  K K Lueders; E L Kuff
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

7.  Retrovirus-related sequences in human DNA: detection and cloning of sequences which hybridize with the long terminal repeat of baboon endogenous virus.

Authors:  M Noda; M Kurihara; T Takano
Journal:  Nucleic Acids Res       Date:  1982-05-11       Impact factor: 16.971

8.  Human breast carcinoma antigen is immunologically related to the polypeptide of the group-specific glycoprotein of mouse mammary tumor virus.

Authors:  T Ohno; R Mesa-Tejada; I Keydar; M Ramanarayanan; J Bausch; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

9.  Identification and cloning of endogenous retroviral sequences present in human DNA.

Authors:  M A Martin; T Bryan; S Rasheed; A S Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Sequence and expression of the mouse mammary tumour virus env gene.

Authors:  S M Redmond; C Dickson
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  129 in total

1.  cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K.

Authors:  C Magin; R Löwer; J Löwer
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein.

Authors:  J Yang; H P Bogerd; S Peng; H Wiegand; R Truant; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 3.  Breast cancer hypothesis: a single cause for the majority of cases.

Authors:  R A Wiseman
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

4.  Breast Cancer: A Revolutionary Concept.

Authors: 
Journal:  Breast Cancer       Date:  1995-04-30       Impact factor: 4.239

5.  A redefinition of the Asp-Asp domain of reverse transcriptases.

Authors:  A M Velasco; L Medrano; A Lazcano; J Oró
Journal:  J Mol Evol       Date:  1992-12       Impact factor: 2.395

6.  Comparative studies of frameshifting and nonframeshifting RNA pseudoknots: a mutational and NMR investigation of pseudoknots derived from the bacteriophage T2 gene 32 mRNA and the retroviral gag-pro frameshift site.

Authors:  Yue Wang; Norma M Wills; Zhihua Du; Anupama Rangan; John F Atkins; Raymond F Gesteland; David W Hoffman
Journal:  RNA       Date:  2002-08       Impact factor: 4.942

7.  Distinct subsets of retroviruses encode dUTPase.

Authors:  J H Elder; D L Lerner; C S Hasselkus-Light; D J Fontenot; E Hunter; P A Luciw; R C Montelaro; T R Phillips
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

8.  Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region.

Authors:  Michaela Mack; Klaus Bender; Peter M Schneider
Journal:  Immunogenetics       Date:  2004-08-12       Impact factor: 2.846

9.  Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.

Authors:  Natalie Sutkowski; Gang Chen; German Calderon; Brigitte T Huber
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  High prevalence of MMTV-like env gene sequences in gestational breast cancer.

Authors:  Y Wang; S M Melana; B Baker; I Bleiweiss; M Fernandez-Cobo; J F Mandeli; J F Holland; B G T Pogo
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.